Repeated prevalence studies of nosocomial infections in one university hospital in Serbia
Repeated prevalence studies of nosocomial infections in one university hospital in Serbia
Background/aim: Nosocomial infections occur worldwide and affect both developed and resource-poor countries. The aim of this paper was to determine the prevalence and risk factors for nosocomial infections in one Serbian hospital. Materials and methods: Three-point prevalence surveys were conducted in the Clinical Center of Kragujevac (1240 beds). The standard definitions for nosocomial infections of the Centers for Diseases Control and Prevention were used. The authors conducted surveys according to the same protocol. Results: The prevalence of infected patients and the overall prevalence of nosocomial infections was 6.2% and 7.1% in 2003, 4.6% and 4.6% in 2005, and 7.6% and 8.7% in 2009, respectively. In all three studies, the risk factors for nosocomial infections were older age, intravascular catheters, urinary catheters, longer hospital stays, hospitalization in an intensive care unit, and surgeries. According to the multivariate regression analysis, a prolonged hospitalization and use of a urinary catheter were independent risk factors for nosocomial infections in the first and second study. Conclusion: The overall healthcare-associated infection prevalence in our hospital increased from 2003 to 2009, and this was an incentive for a better definition of infection control priorities in high-risk departments.
___
- 1. World Health Organization. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. Geneva, Switzerland: WHO; 2011.
- 2. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, Pittet D. Burden of endemic health-careassociated infection in developing countries: systematic review and meta-analysis. Lancet 2011; 377: 228-241.
- 3. Marchetti A, Rossiter R. Economic burden of healthcareassociated infection in US acute care hospitals: societal perspective. J Med Econ 2013; 16: 1399-1404.
- 4. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
- 5. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332.
- 6. Centers for Disease Prevention and Control. CDC/NHSN Surveillance for Specific Types of Infections. Atlanta, GA, USA: CDC; 2016.
- 7. Ministry of Health, Republic of Serbia. Rulebook on Prevention, Early Detection and Suppression of Hospital Infections. Official Gazette No. 101/13. Belgrade, Serbia: Ministry of Health, Republic of Serbia; 2013.
- 8. Mayon-White RT, Ducel G, Kereselidze T, Tikomirov E. An international survey of the prevalence of hospital-acquired infection. J Hosp Infect 1988; 11 (Suppl. A): 43-48.
- 9. Eriksen HM,Iversen BG,Aavitsland P.Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. Hosp Infect 2005; 60: 40-45.
- 10. Gordts B, Vrijens F, Hulstaert F, Devriese S, Van de Sande S. The 2007 Belgian national prevalence survey for hospital-acquired infections. J Hosp Infect 2010; 75: 163-167.
- 11. Sax H, Uçkay I, Balmelli C, Bernasconi E, Boubaker K, Mühlemann K, Ruef C, Troillet N, Widmer A, Zanetti G et al. Overall burden of healthcare-associated infections among surgical patients. Results of a national study. Ann Surg 2011; 253: 365-370.
- 12. Smyth ET, McIlvenny G, Enstone JE, Emmerson AM, Humphreys H, Fitzpatrick F, Davies E, Newcombe RG, Spencer RC; Hospital Infection Society Prevalence Survey Steering Group. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect 2008; 69: 230-248.
- 13. Lyytikäinen O, Kanerva M, Agthe N, Möttönen T, Ruutu P; Finnish Prevalence Survey Study Group. Healthcareassociated infections in Finnish acute care hospitals: a national prevalence survey, 2005. J Hosp Infect 2008; 69: 288-294.
- 14. Ider BE, Clements A, Adams J, Whitby M, Muugolog T. Prevalence of hospital-acquired infections and antibiotic use in two tertiary Mongolian hospitals. J Hosp Infect 2010; 75: 214- 219.
- 15. Faria S, Sodano L, Gjata A, Dauri M, Sabato AF, Bilaj A, Mertiraj O, Llazo E, Kodra Y, Schinaia N et al. The first prevalence survey of nosocomial infections in the University Hospital Centre Mother Teresa of Tirana, Albania. J Hosp Infect 2007; 65: 244-250.
- 16. Ćosić G, Đekić J, Petrović M, Krtinić G, Karać T, Jandrić-Kočić J, Marković-Denić L. The most frequent hospital-acquired infections related to medical interventions in hospitals in Vojvodina province. Arch Bio Sci 2014; 66: 523-535.
- 17. Ministry of Health of the Republic of Serbia. Third National Prevalence Study of Hospital Infections. Belgrade, Serbia: Ministry of Health of the Republic of Serbia; 2012.
- 18. Humphreys H, Smyth ET. Prevalence surveys of healthcareassociated infections: what do they tell us, if anything? Clin Microbiol Infect 2006; 12: 2-4.
- 19. Zhang Y, Zhang J, Wei D, Yang Z, Wang Y, Yao Z. Annual surveys for point-prevalence of healthcare-associated infections in a tertiary hospital in Beijing, China. BMC Infect Dis 2016; 16: 161.
- 20. Hajdu A, Eriksen H, Sorknes N, Hauge S, Loewer H, Iversen H, Aavitsland P. Evaluation of the national surveillance system for point-prevalence of healthcare-associated infections in hospitals and in long-term care facilities for elderly in Norway, 2002-2008. BMC Public Health 2011; 11: 923.
- 21. Drndarević D, Janković S. Hospital infections. Definitions. Textbook 1. 1st ed. Belgrade, Serbia: Srbotampa, 1998.
- 22. Metintas S, Akgun Y, Durmaz G, Kalyoncu C. Prevalence and characteristics of nosocomial infections in a Turkish university hospital. Am J Infect Control 2004; 32: 409-413.
- 23. Kallel H, Bahoul M, Ksibi H, Dammak H, Chelly H, Hamida CB, Chaari A, Rekik N, Bouaziz M. Prevalence of hospitalacquired infection in a Tunisian hospital. J Hosp Infect 2005; 59: 343-347.
- 24. Klavs I, Bufon Luznik T, Skerl M, Grgic-Vitek M, Lejko Zupanc T, Dolinsek M, Prodan V, Vegnuti M, Kraigher A, Arnez Z et al. Prevalence of and risk factors for hospital-acquired infections in Slovenia-results of the first national survey, 2001. J Hosp Infect 2003; 54: 149-157.
- 25. Weinstein JW, Mazon D, Pantelick E, Reagan-Cirincione P, Dembry LM, Hierholzer WJ Jr. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol 1999; 20: 543-548.
- 26. Mihaljević L, Bedenić B, Mihaljević S, Majerović M, Petrović P, Vasilj I. Microbiological surveillance of the surgical intensive care unit in Zagreb--a pivot for guideline-based therapy of severe sepsis. Coll Antropol 2007; 31: 1093-1097.
- 27. Allegranzi B, Nejad SB, Combescure C, Graafmans W, Homa Attar H, Donaldson L, Pittet D. Burden of endemic health-careassociated infection in developing countries: systematic review and meta-analysis. Lancet 2011; 377: 228-241.
- 28. World Health Organization. Report of the Burden of Endemic Health-Care Associated Infections Worldwide. A Systematic Review of the Literature. Geneva, Switzerland: WHO; 2011.
- 29. Nichols RL. Preventing surgical site infections: a surgeons perspective. Emerg Infect Dis 2001; 7: 220-224.
- 30. Lee L, Liao F, Lee C, Huang H, Fang T. Soft tissue infections related to peripheral intravenous catheters in hospitalised patients: a case-control study. J Hosp Infect 2010; 76: 124-129.
- 31. Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001; 7: 342-347.
- 32. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA-J Am Med Assoc 2009; 302: 2323-2329.
- 33. Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L et al. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis 2014; 14: 381-387.